top of page
NECTAR
Novel experimental COVID therapies affecting host response
Sponsor : NEAT ID Foundation & VUMC
Indication: COVID-19
Countries: Brazil, RSA, Germany, Spain, Italy & Argentina
Status: Early reporting and close down activities. The DSMB has stopped Fostamatinib for low conditional power of finding efficacy.
bottom of page